Constipation Nutraceuticals Market Report 2020-2030

Constipation Nutraceuticals Market Report 2020-2030

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

By ordering and reading our brand-new report today you stay better informed and ready to act.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Report Scope

  • Global Constipation Nutraceutiacls Market, 2019-2030
  • Global Constipation Nutraceuticals Market, by Segment
  • Fibers & Specialty Carbohydrates
  • Vitamins
  • Minerals
  • Carotenoids
  • Omega-3 Fatty Acids
  • Prebiotics & Probiotics
  • Amino Acids & Proteins
  • Others
  • Global Constipation Nutraceuticals Market, by Form
  • Dry Form
  • Liquid Form
  • Global Constipation Nutraceuticals Market, by Regions
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • India
  • China
  • Rest of APAC
  • South America
  • Middle East & Africa
  • Leading Companies
  • DuPont de Nemours, Inc.
  • Glanbia plc
  • DSM
  • Associated British Foods, Plc
  • Ingredion Incorporated
  • Tate & Lyle
  • Ajinomoto Group
  • BASF SE
  • Kerry Group
  • Cargill, Inc.
  • ADM
  • Arla Foods
  • Chr. Hansen Holding A/S
Analysis of the Drivers, Restraints, Opportunities and Threats of the Global Constipation Nutraceuticals Market is discussed in the report

The report also includes SWOT Analysis and Porter’s Five Forces Analysis of the Constipation Nutraceuticals Market. The report also identifies the Impact of Coronavirus on the Global Constipation Nutraceuticals Market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Constipation Nutraceuticals Market. You find data, trends and predictions.Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


1. Report Overview
1.1. Global Constipation Nutraceuticals Market Overview
1.2. Global Constipation Nutraceuticals Market Segmentation
1.3. Why You Should Read This Report
1.4. How This Report Delivers
1.5. Key Questions Answered by This Analytical Report
1.6. Who is This Report For?
1.7. Methodology
1.8. Frequently Asked Questions (FAQ)
1.9. Associated Visiongain Reports
1.10. About Visiongain
2. Executive Summary
3. Introduction to Constipation Nutraceuticals Market
3.1. What are Nutraceuticals?
3.2. List of Major Constipation Nutraceutical Ingredients
3.3. Constipation Nutraceuticals Value Chain
3.4. Constipation Nutraceuticals: Market Segmentation
3.4.1. Fibers & Specialty Carbohydrates
3.4.2. Vitamins
3.4.3. Minerals
3.4.4. Carotenoids
3.4.5. Omega 3-Fatty acids
3.4.6. Prebiotics & Probiotics
3.4.7. Amino Acids & Proteins
3.4.8. Others
3.5. Market Dynamics: Global Constipation Nutraceuticals Market
3.5.1. Drivers
3.5.1.1. Rising health consciousness
3.5.1.2. Increasing incidences of chronic diseases
3.5.1.3. Rising healthcare costs
3.5.1.4. Technological inventions in constipation nutraceuticals
3.5.2. Restraints
3.5.2.1. High raw material costs
3.5.2.2. Consumer uncertainty
3.5.3. Opportunities
3.5.3.1. Increasing Target Population
3.5.3.2. Economic growth in the Emerging Markets
3.5.3.3. Technological Inventions
3.6. SWOT Analysis: Global Constipation Nutraceuticals Market
3.6.1. Strengths
3.6.2. Weaknesses
3.6.3. Opportunities
3.6.4. Threats
3.7. Porter’s Five Forces Analysis: Global Constipation Nutraceuticals Market
3.7.1. Bargaining power of suppliers
3.7.2. Bargaining power of buyers
3.7.3. Threat of new entrants
3.7.4. Threat of Substitutes
3.7.5. Competitive Rivalry
4. Impact of Coronavirus (COVID-19)
4.1. Possible impact scenarios of COVID-19
4.1.1. ‘V’ shaped recovery model
4.1.2. ‘U’ shaped recovery model
4.1.3. ‘L’ shaped recovery model
4.1.4. ‘W’ shaped recovery model
4.1.5. Conclusion
5. Global Constipation Nutraceuticals Market by Product, 2019-2030
5.1. Leading Constipation Nutraceuticals in 2020
5.2. Global Constipation Nutraceuticals Market, by Segment – Coronavirus Impact Scenario
5.2.1. ‘V’ Shaped Recovery Model
5.2.2. ‘U’ Shaped Recovery Model
5.2.3. ‘L’ Shaped Recovery Model
5.2.4. ‘W’ Shaped Recovery Model
5.3. Fibers & Specialty Carbohydrates
5.4. Vitamins
5.5. Minerals
5.6. Carotenoids
5.7. Omega-3 Fatty Acids
5.8. Prebiotics & Probiotics
5.9. Amino Acids & Proteins
6. Global Constipation Nutraceuticals Market by Form, 2019-2030
6.1. Leading Constipation Nutraceuticals Form in 2020
6.2. Global Constipation Nutraceuticals Market, by Form – Coronavirus Impact Scenario
6.2.1. ‘V’ Shaped Recovery Model
6.2.2. ‘U’ Shaped Recovery Model
6.2.3. ‘L’ Shaped Recovery Model
6.2.4. ‘W’ Shaped Recovery Model
6.3. Dry Form
6.4. Liquid Form
7. Global Constipation Nutraceuticals Market by Regions, 2019-2030
7.1. The Global Constipation Nutraceuticals Market Overview
7.2. Segmenting the Global Constipation Nutraceuticals Market
7.3. Definitions and Regulations of Nutraceuticals in Different Geographies Globally
7.3.1. Changes in the Global Constipation Nutraceuticals Market Share – 2019, 2025 and 2030
7.4. Global Constipation Nutraceuticals Market, by Geography – Coronavirus Impact Scenario
7.4.1. ‘V’ Shaped Recovery Model
7.4.2. ‘U’ Shaped Recovery Model
7.4.3. ‘L’ Shaped Recovery Model
7.4.4. ‘W’ Shaped Recovery Model
7.5. North America Constipation Nutraceuticals Market
7.5.1. North America Constipation Nutraceuticals Market by Product
7.5.2. North America Constipation Nutraceuticals Market by Form
7.5.3. North America Constipation Nutraceuticals Market by Country
7.5.4. North America Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.5.4.1. ‘V’ Shaped Recovery Model
7.5.4.2. ‘U’ Shaped Recovery Model
7.5.4.3. ‘L’ Shaped Recovery Model
7.5.4.4. ‘W’ Shaped Recovery Model
7.5.5. U.S.
7.5.5.1. U.S. Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.5.5.1.1. ‘V’ Shaped Recovery Model
7.5.5.1.2. ‘U’ Shaped Recovery Model
7.5.5.1.3. ‘L’ Shaped Recovery Model
7.5.5.1.4. ‘W’ Shaped Recovery Model
7.5.6. Canada
7.5.6.1. Canada Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.5.6.1.1. ‘V’ Shaped Recovery Model
7.5.6.1.2. ‘U’ Shaped Recovery Model
7.5.6.1.3. ‘L’ Shaped Recovery Model
7.5.6.1.4. ‘W’ Shaped Recovery Model
7.6. Europe
7.6.1. Europe Constipation Nutraceuticals Market by Product
7.6.2. Europe Constipation Nutraceuticals Market by Form
7.6.3. Europe Constipation Nutraceuticals Market by Country
7.6.4. Europe Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.6.4.1. ‘V’ Shaped Recovery Model
7.6.4.2. ‘U’ Shaped Recovery Model
7.6.4.3. ‘L’ Shaped Recovery Model
7.6.4.4. ‘W’ Shaped Recovery Model
7.6.5. Germany
7.6.5.1. Germany Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.6.5.1.1. ‘V’ Shaped Recovery Model
7.6.5.1.2. ‘U’ Shaped Recovery Model
7.6.5.1.3. ‘L’ Shaped Recovery Model
7.6.5.1.4. ‘W’ Shaped Recovery Model
7.6.6. U.K.
7.6.6.1. U.K. Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.6.6.1.1. ‘V’ Shaped Recovery Model
7.6.6.1.2. ‘U’ Shaped Recovery Model
7.6.6.1.3. ‘L’ Shaped Recovery Model
7.6.6.1.4. ‘W’ Shaped Recovery Model
7.6.7. France
7.6.7.1. France Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.6.7.1.1. ‘V’ Shaped Recovery Model
7.6.7.1.2. ‘U’ Shaped Recovery Model
7.6.7.1.3. ‘L’ Shaped Recovery Model
7.6.7.1.4. ‘W’ Shaped Recovery Model
7.6.8. Italy
7.6.8.1. Italy Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.6.8.1.1. ‘V’ Shaped Recovery Model
7.6.8.1.2. ‘U’ Shaped Recovery Model
7.6.8.1.3. ‘L’ Shaped Recovery Model
7.6.8.1.4. ‘W’ Shaped Recovery Model
7.6.9. Spain
7.6.9.1. Spain Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.6.9.1.1. ‘V’ Shaped Recovery Model
7.6.9.1.2. ‘U’ Shaped Recovery Model
7.6.9.1.3. ‘L’ Shaped Recovery Model
7.6.9.1.4. ‘W’ Shaped Recovery Model
7.6.10. Rest of Europe
7.6.10.1. Rest of Europe Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.6.10.1.1. ‘V’ Shaped Recovery Model
7.6.10.1.2. ‘U’ Shaped Recovery Model
7.6.10.1.3. ‘L’ Shaped Recovery Model
7.6.10.1.4. ‘W’ Shaped Recovery Model
7.7. Asia-Pacific
7.7.1. Asia-Pacific Constipation Nutraceuticals Market by Product
7.7.2. Asia-Pacific Constipation Nutraceuticals Market by Form
7.7.3. Asia-Pacific Constipation Nutraceuticals Market by Country
7.7.4. Asia-Pacific Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.7.4.1. ‘V’ Shaped Recovery Model
7.7.4.2. ‘U’ Shaped Recovery Model
7.7.4.3. ‘L’ Shaped Recovery Model
7.7.4.4. ‘W’ Shaped Recovery Model
7.7.5. Japan
7.7.5.1. Japan Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.7.5.1.1. ‘V’ Shaped Recovery Model
7.7.5.1.2. ‘U’ Shaped Recovery Model
7.7.5.1.3. ‘L’ Shaped Recovery Model
7.7.5.1.4. ‘W’ Shaped Recovery Model
7.7.6. China
7.7.6.1. China Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.7.6.1.1. ‘V’ Shaped Recovery Model
7.7.6.1.2. ‘U’ Shaped Recovery Model
7.7.6.1.3. ‘L’ Shaped Recovery Model
7.7.6.1.4. ‘W’ Shaped Recovery Model
7.7.7. India
7.7.7.1. India Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.7.7.1.1. ‘V’ Shaped Recovery Model
7.7.7.1.2. ‘U’ Shaped Recovery Model
7.7.7.1.3. ‘L’ Shaped Recovery Model
7.7.7.1.4. ‘W’ Shaped Recovery Model
7.7.8. Rest of Asia-Pacific
7.7.8.1. Rest of Asia-Pacific Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.7.8.1.1. ‘V’ Shaped Recovery Model
7.7.8.1.2. ‘U’ Shaped Recovery Model
7.7.8.1.3. ‘L’ Shaped Recovery Model
7.7.8.1.4. ‘W’ Shaped Recovery Model
7.8. South America
7.8.1. South America Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.8.1.1. ‘V’ Shaped Recovery Model
7.8.1.2. ‘U’ Shaped Recovery Model
7.8.1.3. ‘L’ Shaped Recovery Model
7.8.1.4. ‘W’ Shaped Recovery Model
7.8.2. South America Constipation Nutraceuticals Market by Product
7.8.3. South America Constipation Nutraceuticals Market by Form
7.9. Middle-East & Africa
7.9.1. MEA Constipation Nutraceuticals Market, Coronavirus Impact Scenario
7.9.1.1. ‘V’ Shaped Recovery Model
7.9.1.2. ‘U’ Shaped Recovery Model
7.9.1.3. ‘L’ Shaped Recovery Model
7.9.1.4. ‘W’ Shaped Recovery Model
7.9.2. MEA Constipation Nutraceuticals Market by Product
7.9.3. MEA Constipation Nutraceuticals Market by Form
8. Company Profiles
8.1. Competitive Analysis
8.2. DuPont de Nemours, Inc.
8.2.1. DuPont Financial Outlook
8.2.2. DuPont Product Portfolio
8.2.3. DuPont, Inc. Strategic Developments
8.3. Glanbia plc
8.3.1. Glanbia Financial Outlook
8.3.2. Glanbia Product Portfolio
8.3.3. Glanbia plc Strategic Developments
8.4. DSM
8.4.1. DSM Financial Outlook
8.4.2. DSM Product Portfolio
8.4.3. DSM Strategic Developments
8.5. Associated British Foods, Plc
8.5.1. Associated British Foods: Financial Outlook
8.5.2. Associated British Foods Product Portfolio
8.5.3. Associated British Foods Strategic Developments
8.6. Ingredion Incorporated
8.6.1. Ingredion Incorporated: Financial Outlook
8.6.2. Ingredion Incorporated: Product Portfolio
8.6.3. Ingredion Incorporated: Strategic Developments
8.7. Tate & Lyle
8.7.1. Tate & Lyle: Financial Outlook
8.7.2. Tate & Lyle: Product Portfolio
8.7.3. Tate & Lyle: Strategic Developments
8.8. Ajinomoto Group
8.8.1. Ajinomoto Group: Financial Outlook
8.8.2. Ajinomoto Group: Product Portfolio
8.8.3. Ajinomoto Group: Strategic Developments
8.9. BASF SE
8.9.1. BASF: Financial Outlook
8.9.2. BASF: Product Portfolio
8.9.3. BASF: Strategic Developments
8.10. Kerry Group
8.10.1. Kerry Group: Financial Outlook
8.10.2. Kerry Group: Product Portfolio
8.10.3. Kerry Group: Strategic Developments
8.11. Cargill, Inc.
8.11.1. Cargill, Inc.: Financial Outlook
8.11.2. Cargill, Inc.: Product Portfolio
8.11.3. Cargill, Inc.: Strategic Developments
8.12. ADM
8.12.1. ADM: Financial Outlook
8.12.2. ADM: Product Portfolio
8.12.3. ADM: Strategic Developments
8.13. Arla Foods
8.13.1. Arla Foods: Financial Outlook
8.13.2. Arla Foods: Product Portfolio
8.13.3. Arla Foods: Strategic Developments
8.14. Chr. Hansen Holding A/S
8.14.1. Chr. Hansen Holding A/S: Financial Outlook
8.14.2. Chr. Hansen Holding A/S: Product Portfolio
9. Conclusion
9.1. Overview of the Current Market Conditions and Market Forecast, 2019-2030
9.2. Leading Segments in the Global Constipation Nutraceuticals
9.2.1. Leading Constipation Nutraceuticals, By Brands, 2019
9.3. Leading Regions in the Global Constipation Nutraceuticals Market
Visiongain Report Sales Order Form
Appendix A: About Visiongain
Appendix B: Visiongain report evaluation form
List of Tables
Table 1 Global Constipation Nutraceuticals Market: Revenue Snapshot
Table 2 Major Constipation Nutraceutical Ingredients
Table 3 Value Chain: Nutraceuticals
Table 4 Global Constipation Nutraceuticals V-Shaped Market Scenario And Forecast By Product, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 5 Global Constipation Nutraceuticals V-Shaped Market Scenario And Forecast By Form, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 6 Global Constipation Nutraceuticals V-Shaped Market Scenario And Forecast By Region, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 7 Global Constipation Nutraceuticals U-Shaped Market Scenario And Forecast By Product, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 8 Global Constipation Nutraceuticals U-Shaped Market Scenario And Forecast By Form, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 9 Global Constipation Nutraceuticals U-Shaped Market Scenario And Forecast By Region, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 10 Global Constipation Nutraceuticals L-Shaped Market Scenario And Forecast By Product, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 11 Global Constipation Nutraceuticals L-Shaped Market Scenario And Forecast By Form, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 12 Global Constipation Nutraceuticals L-Shaped Market Scenario And Forecast By Region, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 13 Global Constipation Nutraceuticals W-Shaped Market Scenario And Forecast By Product, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 14 Global Constipation Nutraceuticals W-Shaped Market Scenario And Forecast By Form, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 15 Global Constipation Nutraceuticals W-Shaped Market Scenario And Forecast By Region, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030
Table 16 Global Constipation Nutraceuticals Market And Forecast By Segment Market Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 17 Global Constipation Nutraceuticals Market And Forecast By Segment ‘V’ Shaped Recovery Model: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 18 Global Constipation Nutraceuticals Market And Forecast By Segment ‘U’ Shaped Recovery Model: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 19 Global Constipation Nutraceuticals Market And Forecast By Segment ‘L’ Shaped Recovery Model: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 20 Global Constipation Nutraceuticals Market And Forecast By Segment ‘W’ Shaped Recovery Model: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 21 Global Fibers & Specialty Carbohydrates Market And Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 22 Global Vitamins Market And Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 23 Global Minerals Market And Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 24 Global Carotenoids Market And Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 25 Global Omega-3 Fatty Acids Market And Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 26 Global Prebiotics & Probiotics Market And Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 27 Global Amino Acids & Proteins Market And Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 28 Global Constipation Nutraceuticals Market And Forecast, By Form Market Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 29 Global Constipation Nutraceuticals Market And Forecast By Form ‘V’ Shaped Recovery Model: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 30 Global Constipation Nutraceuticals Market And Forecast By Form ‘U’ Shaped Recovery Model: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 31 Global Constipation Nutraceuticals Market And Forecast By Form ‘L’ Shaped Recovery Model: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 32 Global Constipation Nutraceuticals Market And Forecast By Form ‘W’ Shaped Recovery Model: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 33 Global Dry Form Nutraceuticals Market And Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 34 Global Liquid Form Nutraceuticals Market And Forecast: Revenues ($B), AGR (%) And CAGR (%), 2019-2030
Table 35 Global Constipation Nutraceuticals Market And Forecast, By Region Market Forecast: Revenue ($bn), AGR (%), And CAGR (%), 2019-2030
Table 36 Global Constipation Nutraceuticals Market And Forecast: Market Share By Region, 2019, 2025 And 2030
Table 37 Global Constipation Nutraceuticals V-Shaped Market Scenario And Forecast By Region, Revenue ($bn), AGR (%) And CAGR (%), 2019-2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook